Facebook Twitter LinkedIn Instagram Email Printer Google Plus

COVID-19

Hospitals nationwide could near collapse as the pandemic straps them of necessary resources.

Partner & Co-Head – Risk & Public Policy, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

The nation's new "normal" may not come until Q4 of 2021. Companies must consider what is sustainable and where to adjust for the long haul.

Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman

Featured in the World Economic Forum Agenda

When the pandemic first struck, it fuelled efforts to unify and overcome a crisis. Then, hope dwindled.

Partner, Organizational Effectiveness, Oliver Wyman

Critical Capabilities For Effective Liquidity Management During COVID-19

The pandemic has exposed gaps in decision-making tools and capabilities. Endurance is the key to navigating uncharted waters.

Partner, Financial Services, Oliver Wyman
Partner, Financial Services, Oliver Wyman
Partner, Financial Services, Oliver Wyman
Principal, Financial Services, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

As parts of the nation begin to re-open, new considerations are unfolding that leaders struggle to manage.

Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Employees who have a sense of purpose tied to something much greater than themselves will thrive emotionally during COVID-19.

Partner, Mercer

COVID-19 is here to stay. In the meantime, hospitals' roles are greatly expanding.

Partner and CMO, Health and Life Sciences, Oliver Wyman

Considerations for the pricing of health insurance products amidst a global crisis.

Partner, Health and Life Sciences, Oliver Wyman
Senior Advisor, Health & Life Sciences, Oliver Wyman

Part 2: Healthcare’s ‘Corona Effect’

Ten expectations regarding voluntary offerings, telemedicine, direct contracting, and more as COVID-19 unfolds.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Times of turmoil caused by COVID-19 allow for the formation of deeper relationships with customers, members, and society.

Partner, Health & Life Sciences, Oliver Wyman
Global Head, Health Services, Oliver Wyman

Insights in your inbox

Subscribe